ArticleInternational journal of cancer2021

A Phase I dose-escalation study of two cycles carboplatin-olaparib followed by olaparib monotherapy in patients with advanced cancer.

Jill J J Geenen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.